F9 Embryonal Carcinoma Cells Engineered for Tamoxifen-Dependent Cre-Mediated Site-Directed Mutagenesis and Doxycycline-Inducible Gene Expression
- 1 November 2000
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 260 (2) , 334-339
Abstract
No abstract availableKeywords
Funding Information
- Institut National de la Santé et de la Recherche Médicale
- Centre National de la Recherche Scientifique
- Bristol-Myers Squibb
- Fondation pour la Recherche Médicale
- Human Frontier Science Program
- Association pour la Recherche sur le Cancer
This publication has 30 references indexed in Scilit:
- Diverse strategies for tetracycline-regulated inducible gene expression.Proceedings of the National Academy of Sciences, 1996
- Recent advances in gene mutagenesis by site-directed recombination.Journal of Clinical Investigation, 1996
- Transcriptional Activation by Tetracyclines in Mammalian CellsScience, 1995
- [31] Use of tetracycline operator system to regulate oncogene expression in mammalian cells1995
- [24] Tightly regulated and inducible expression of dominant interfering dynamin mutant in stably transformed HeLa cells1995
- TKO'ed: Lox, stock and barrelBioEssays, 1994
- Site-specific recombination: developments and applicationsCurrent Opinion in Biotechnology, 1994
- Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elementsTrends in Biochemical Sciences, 1993
- Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.Proceedings of the National Academy of Sciences, 1992
- Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1.Proceedings of the National Academy of Sciences, 1988